The global market for Drug Discovery Biosimulation Software was valued at US$ 1020 million in the year 2024 and is projected to reach a revised size of US$ 2124 million by 2031, growing at a CAGR of 11.1% during the forecast period.
Drug discovery biosimulation software refers to a professional software tool that uses computer modeling, mathematical algorithms, and bioinformatics techniques to simulate and predict the interactions between drug molecules and biological systems (such as proteins, cells, tissues, or the entire organism). This type of software can predict the pharmacological activity, toxicity, and pharmacokinetic properties of candidate compounds in a virtual environment by establishing quantitative structure-activity relationships (QSAR), molecular dynamics simulations, systems biology models, and other methods, thereby significantly reducing the laboratory testing and animal experiments required in traditional drug discovery processes.
The global market for biosimulation software for drug discovery has shown a steady growth trend in recent years. Biological simulation technology can help pharmaceutical companies reduce research and development costs and shorten research and development cycles. The cost-benefit ratio is particularly important in the context of patent cliff and medical expenditure control. Regulatory agencies such as the US FDA and European EMA are increasingly accepting modeling and simulation data as auxiliary evidence for new drug applications. The integration of artificial intelligence algorithms, high-performance computing, and biological big data analysis has significantly improved the predictive accuracy and applicability of biological simulations, making them gradually become one of the core methods for drug discovery from auxiliary tools. The rise of precision medicine and personalized dosing regimens has increased the demand for patient specific simulations, driving the expansion of the application of biosimulation software in preclinical and clinical stages. North America currently holds the largest market share, followed by Europe and the Asia Pacific region. The market presents a diversified competitive pattern and moderate concentration characteristics. The main participants include well-known companies such as Biolauncher, Certara, Dassault Systemes, etc. Leading companies mainly maintain and expand their market position through technological innovation, strategic mergers and acquisitions, partnerships, and cloud service transformation. In the Chinese market, core technologies and high-end markets are still dominated by international giants, but local enterprises such as Tencent AI Lab and PharmaResources are gradually increasing their influence through independent research and development and strategic cooperation. In the future, the integration of artificial intelligence will become the most significant trend in technological development. The new generation of AI driven simulation tools can learn complex patterns from massive biomedical data and achieve higher precision predictions. The next generation of biological simulation software will have the ability to integrate and analyze multidimensional data such as genomics, proteomics, metabolomics, etc., and construct multi-scale models that are closer to real biological systems.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Biosimulation Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Biosimulation Software.
The Drug Discovery Biosimulation Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Discovery Biosimulation Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Biosimulation Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biolauncher
Pfizer
Dassault Systemes
Novartis
Schrodinger
AstraZeneca
Insilico Medicine
Simulations Plus
Molecular Networks
Evotec
Boehringer Ingelheim
Certara
Tencent AI Lab
PharmaResources
Quantum Hi-Tech (China) Biotechnology
Leto Laboratories
Zuoshouyisheng
Taimei Technology
AIxplorerbio
Moore Threads
StoneWise
NovaX Biotech
Segment by Type
Molecular Modeling And Structural Prediction Software
Virtual Screening And Molecular Design Software
ADMET Prediction Software
Molecular Dynamics Simulation Software
Systems Biology And Multiscale Modeling Software
Others
Segment by Application
Target Recognition
Virtual Screening
Lead Optimization
Pharmacokinetic Simulation
Toxic Predicting
Mechanism Analysis
Effect Analysis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Biosimulation Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Biosimulation Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Modeling And Structural Prediction Software
1.2.3 Virtual Screening And Molecular Design Software
1.2.4 ADMET Prediction Software
1.2.5 Molecular Dynamics Simulation Software
1.2.6 Systems Biology And Multiscale Modeling Software
1.2.7 Others
1.3 Market by Application
1.3.1 Global Drug Discovery Biosimulation Software Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Target Recognition
1.3.3 Virtual Screening
1.3.4 Lead Optimization
1.3.5 Pharmacokinetic Simulation
1.3.6 Toxic Predicting
1.3.7 Mechanism Analysis
1.3.8 Effect Analysis
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Biosimulation Software Market Perspective (2020-2031)
2.2 Global Drug Discovery Biosimulation Software Growth Trends by Region
2.2.1 Global Drug Discovery Biosimulation Software Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Discovery Biosimulation Software Historic Market Size by Region (2020-2025)
2.2.3 Drug Discovery Biosimulation Software Forecasted Market Size by Region (2026-2031)
2.3 Drug Discovery Biosimulation Software Market Dynamics
2.3.1 Drug Discovery Biosimulation Software Industry Trends
2.3.2 Drug Discovery Biosimulation Software Market Drivers
2.3.3 Drug Discovery Biosimulation Software Market Challenges
2.3.4 Drug Discovery Biosimulation Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Biosimulation Software Players by Revenue
3.1.1 Global Top Drug Discovery Biosimulation Software Players by Revenue (2020-2025)
3.1.2 Global Drug Discovery Biosimulation Software Revenue Market Share by Players (2020-2025)
3.2 Global Top Drug Discovery Biosimulation Software Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Discovery Biosimulation Software Revenue
3.4 Global Drug Discovery Biosimulation Software Market Concentration Ratio
3.4.1 Global Drug Discovery Biosimulation Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Biosimulation Software Revenue in 2024
3.5 Global Key Players of Drug Discovery Biosimulation Software Head office and Area Served
3.6 Global Key Players of Drug Discovery Biosimulation Software, Product and Application
3.7 Global Key Players of Drug Discovery Biosimulation Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Biosimulation Software Breakdown Data by Type
4.1 Global Drug Discovery Biosimulation Software Historic Market Size by Type (2020-2025)
4.2 Global Drug Discovery Biosimulation Software Forecasted Market Size by Type (2026-2031)
5 Drug Discovery Biosimulation Software Breakdown Data by Application
5.1 Global Drug Discovery Biosimulation Software Historic Market Size by Application (2020-2025)
5.2 Global Drug Discovery Biosimulation Software Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Discovery Biosimulation Software Market Size (2020-2031)
6.2 North America Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
6.4 North America Drug Discovery Biosimulation Software Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Biosimulation Software Market Size (2020-2031)
7.2 Europe Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
7.4 Europe Drug Discovery Biosimulation Software Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Biosimulation Software Market Size (2020-2031)
8.2 Asia-Pacific Drug Discovery Biosimulation Software Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Biosimulation Software Market Size (2020-2031)
9.2 Latin America Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
9.4 Latin America Drug Discovery Biosimulation Software Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Biosimulation Software Market Size (2020-2031)
10.2 Middle East & Africa Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biolauncher
11.1.1 Biolauncher Company Details
11.1.2 Biolauncher Business Overview
11.1.3 Biolauncher Drug Discovery Biosimulation Software Introduction
11.1.4 Biolauncher Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.1.5 Biolauncher Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drug Discovery Biosimulation Software Introduction
11.2.4 Pfizer Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Dassault Systemes
11.3.1 Dassault Systemes Company Details
11.3.2 Dassault Systemes Business Overview
11.3.3 Dassault Systemes Drug Discovery Biosimulation Software Introduction
11.3.4 Dassault Systemes Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.3.5 Dassault Systemes Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Drug Discovery Biosimulation Software Introduction
11.4.4 Novartis Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Schrodinger
11.5.1 Schrodinger Company Details
11.5.2 Schrodinger Business Overview
11.5.3 Schrodinger Drug Discovery Biosimulation Software Introduction
11.5.4 Schrodinger Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.5.5 Schrodinger Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Drug Discovery Biosimulation Software Introduction
11.6.4 AstraZeneca Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Insilico Medicine
11.7.1 Insilico Medicine Company Details
11.7.2 Insilico Medicine Business Overview
11.7.3 Insilico Medicine Drug Discovery Biosimulation Software Introduction
11.7.4 Insilico Medicine Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.7.5 Insilico Medicine Recent Development
11.8 Simulations Plus
11.8.1 Simulations Plus Company Details
11.8.2 Simulations Plus Business Overview
11.8.3 Simulations Plus Drug Discovery Biosimulation Software Introduction
11.8.4 Simulations Plus Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.8.5 Simulations Plus Recent Development
11.9 Molecular Networks
11.9.1 Molecular Networks Company Details
11.9.2 Molecular Networks Business Overview
11.9.3 Molecular Networks Drug Discovery Biosimulation Software Introduction
11.9.4 Molecular Networks Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.9.5 Molecular Networks Recent Development
11.10 Evotec
11.10.1 Evotec Company Details
11.10.2 Evotec Business Overview
11.10.3 Evotec Drug Discovery Biosimulation Software Introduction
11.10.4 Evotec Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.10.5 Evotec Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Drug Discovery Biosimulation Software Introduction
11.11.4 Boehringer Ingelheim Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Certara
11.12.1 Certara Company Details
11.12.2 Certara Business Overview
11.12.3 Certara Drug Discovery Biosimulation Software Introduction
11.12.4 Certara Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.12.5 Certara Recent Development
11.13 Tencent AI Lab
11.13.1 Tencent AI Lab Company Details
11.13.2 Tencent AI Lab Business Overview
11.13.3 Tencent AI Lab Drug Discovery Biosimulation Software Introduction
11.13.4 Tencent AI Lab Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.13.5 Tencent AI Lab Recent Development
11.14 PharmaResources
11.14.1 PharmaResources Company Details
11.14.2 PharmaResources Business Overview
11.14.3 PharmaResources Drug Discovery Biosimulation Software Introduction
11.14.4 PharmaResources Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.14.5 PharmaResources Recent Development
11.15 Quantum Hi-Tech (China) Biotechnology
11.15.1 Quantum Hi-Tech (China) Biotechnology Company Details
11.15.2 Quantum Hi-Tech (China) Biotechnology Business Overview
11.15.3 Quantum Hi-Tech (China) Biotechnology Drug Discovery Biosimulation Software Introduction
11.15.4 Quantum Hi-Tech (China) Biotechnology Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.15.5 Quantum Hi-Tech (China) Biotechnology Recent Development
11.16 Leto Laboratories
11.16.1 Leto Laboratories Company Details
11.16.2 Leto Laboratories Business Overview
11.16.3 Leto Laboratories Drug Discovery Biosimulation Software Introduction
11.16.4 Leto Laboratories Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.16.5 Leto Laboratories Recent Development
11.17 Zuoshouyisheng
11.17.1 Zuoshouyisheng Company Details
11.17.2 Zuoshouyisheng Business Overview
11.17.3 Zuoshouyisheng Drug Discovery Biosimulation Software Introduction
11.17.4 Zuoshouyisheng Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.17.5 Zuoshouyisheng Recent Development
11.18 Taimei Technology
11.18.1 Taimei Technology Company Details
11.18.2 Taimei Technology Business Overview
11.18.3 Taimei Technology Drug Discovery Biosimulation Software Introduction
11.18.4 Taimei Technology Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.18.5 Taimei Technology Recent Development
11.19 AIxplorerbio
11.19.1 AIxplorerbio Company Details
11.19.2 AIxplorerbio Business Overview
11.19.3 AIxplorerbio Drug Discovery Biosimulation Software Introduction
11.19.4 AIxplorerbio Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.19.5 AIxplorerbio Recent Development
11.20 Moore Threads
11.20.1 Moore Threads Company Details
11.20.2 Moore Threads Business Overview
11.20.3 Moore Threads Drug Discovery Biosimulation Software Introduction
11.20.4 Moore Threads Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.20.5 Moore Threads Recent Development
11.21 StoneWise
11.21.1 StoneWise Company Details
11.21.2 StoneWise Business Overview
11.21.3 StoneWise Drug Discovery Biosimulation Software Introduction
11.21.4 StoneWise Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.21.5 StoneWise Recent Development
11.22 NovaX Biotech
11.22.1 NovaX Biotech Company Details
11.22.2 NovaX Biotech Business Overview
11.22.3 NovaX Biotech Drug Discovery Biosimulation Software Introduction
11.22.4 NovaX Biotech Revenue in Drug Discovery Biosimulation Software Business (2020-2025)
11.22.5 NovaX Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Biolauncher
Pfizer
Dassault Systemes
Novartis
Schrodinger
AstraZeneca
Insilico Medicine
Simulations Plus
Molecular Networks
Evotec
Boehringer Ingelheim
Certara
Tencent AI Lab
PharmaResources
Quantum Hi-Tech (China) Biotechnology
Leto Laboratories
Zuoshouyisheng
Taimei Technology
AIxplorerbio
Moore Threads
StoneWise
NovaX Biotech
听
听
*If Applicable.
